ENU Pharma is a pharmaceutical business committed to doing innovative research, creating medicines, and raising global healthcare standards.
ENU Pharma has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
ENU Pharma's investors include Kyoto University Innovation Capital, DG Incubation, Hokkaido Co-Creation Partners, Taiho Innovations.
ENU Pharma is headquartered in Sapporo, Japan.
ENU Pharma is a pharmaceutical business committed to doing innovative research, creating medicines, and raising global healthcare standards.
ENU Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ENU Pharma — Funding & Investors." VCBacked, December 1, 2024, https://www.vcbacked.co/company/enu-pharma. Accessed August 14, 2026.
VCBacked. (2024). ENU Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/enu-pharma
{{cite web |title=ENU Pharma — Funding & Investors |url=https://www.vcbacked.co/company/enu-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated